Shares of Moderna Inc. MRNA slipped 2.03% to $112.75 Friday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index COMP rising 1.03% to 13,201.98 and the Dow Jones Industrial Average DJIA rising 0.18% to 31,097.97. This was the stock’s second consecutive day of losses. Moderna Inc. closed $65.75 below its 52-week high ($178.50), which the company reached on December 1st.
The stock underperformed when compared to some of its competitors Friday, as AbbVie Inc. ABBV rose 0.52% to $107.27, Amgen Inc. AMGN rose 1.91% to $238.49, and AstraZeneca PLC ADR AZN rose 1.33% to $50.86. Trading volume (12.3 M) remained 13.6 million below its 50-day average volume of 25.9 M.